Abstract
Routine isolation, estimation, and characterization of glycosaminoglycans (GAGs) is quite challenging. This is compounded by the fact that the analysis is technique-intensive and more often there will be a limitation on the quantity of GAGs available for various structural, functional and biological studies. In such a scenario, the sample which can be made available for estimation and elucidation of disaccharide composition and species composition as well remains a challenge. In the present study, we have determined the feasibility where isolated sulfated GAGs (sGAG) that is estimated by metachromasia is recovered for further analysis. sGAG-DMMB complex formed after estimation of sGAG by DMMB dye-binding assay was decomplexed and sGAGs were recovered. Recovered sGAGs were analysed by cellulose acetate membrane electrophoresis and taken up for disaccharide composition analysis by HPLC after fluorescent labelling. Good recovery of sGAGs after metachromasia was observed in all samples of varying levels of purity by this protocol. Further analysis using cellulose acetate membrane electrophoresis showed good separation between species of sGAGs namely chondroitin/dermatan sulfate and heparan sulfate, with comparatively lesser interference from hyaluronic acid, a non-sulfated GAG. Analysis of recovered sGAGs, specifically heparan sulfate by HPLC showed characteristic disaccharide composition akin to that of GAG obtained by the conventional protocol. Thus, in the present paper, we show that sGAG can be recovered in comparatively purer form after routine estimation and can be used for further analysis thus saving up on the precious sample.
Similar content being viewed by others
Abbreviations
- CS:
-
Chondroitin sulfate
- DS:
-
Dermatan sulfate
- GAGs:
-
Glycosaminoglycans
- HA:
-
Hyaluronic acid
- HS:
-
Heparan sulfate
References
Gowd, V., Gurukar, A., Chilkunda, N.D.: Glycosaminoglycan remodeling during diabetes and the role of dietary factors in their modulation. World J. Diabetes. 7, 67–73 (2016). https://doi.org/10.4239/wjd.v7.i4.67
Nagai, N., Habuchi, H., Sugaya, N., Nakamura, M., Imamura, T., Watanabe, H., Kimata, K.: Involvement of heparan sulfate 6-O-sulfation in the regulation of energy metabolism and the alteration of thyroid hormone levels in male mice. Glycobiology. 23, 980–992 (2013). https://doi.org/10.1093/glycob/cwt037
Afratis, N., Gialeli, C., Nikitovic, D., Tsegenidis, T., Karousou, E., Theocharis, A.D., Pavão, M.S., Tzanakakis, G.N., Karamanos, N.K.: Glycosaminoglycans: key players in cancer cell biology and treatment. FEBS J. 279, 1177–1197 (2012). https://doi.org/10.1111/j.1742-4658.2012.08529.x
Reddy, G.K., Dhar, S.C.: Metabolism of glycosaminoglycans in tissues of adjuvant arthritic rat. Mol. Cell. Biochem. 106, 117–124 (1991)
Papakonstantinou, E., Karakiulakis, G.: The “sweet” and “bitter” involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance. Br. J. Pharmacol. 157, 1111–1127 (2009). https://doi.org/10.1111/j.1476-5381.2009.00279.x
Kiran, G., Srikanth, C.B., Salimath, P.V., Nandini, C.D.: Diet-induced hypercholesterolemia imparts structure-function changes to erythrocyte chondroitin sulphate/dermatan sulphate. J. Biochem. (Tokyo). 158, 217–224 (2015). https://doi.org/10.1093/jb/mvv037
Srikanth, C.B., Salimath, P.V., Nandini, C.D.: Erythrocytes express chondroitin sulphate/dermatan sulphate, which undergoes quantitative changes during diabetes and mediate erythrocyte adhesion to extracellular matrix components. Biochimie. 94, 1347–1355 (2012). https://doi.org/10.1016/j.biochi.2012.03.002
Joladarashi, D., Salimath, P.V., Chilkunda, N.D.: Diabetes results in structural alteration of chondroitin sulfate/dermatan sulfate in the rat kidney: effects on the binding to extracellular matrix components. Glycobiology. 21, 960–972 (2011). https://doi.org/10.1093/glycob/cwr029
Lemmnitzer, K., Griesinger, H., Süß, R., Matheis, K., Schulz, M., Schiller, J.: Analysis of glycosaminoglycan oligosaccharides by combined HPTLC/MALDI-TOF MS: reduced silica gel thickness leads to improved spectral qualities and reduced side reactions. Chromatographia. 78, 1409–1413 (2015). https://doi.org/10.1007/s10337-015-2971-2
Pomin, V.H., Sharp, J.S., Li, X., Wang, L., Prestegard, J.H.: Characterization of glycosaminoglycans by 15N NMR spectroscopy and in vivo isotopic labeling. Anal. Chem. 82, 4078–4088 (2010). https://doi.org/10.1021/ac1001383
Osago, H., Shibata, T., Hara, N., Kuwata, S., Kono, M., Uchio, Y., Tsuchiya, M.: Quantitative analysis of glycosaminoglycans, chondroitin/dermatan sulfate, hyaluronic acid, heparan sulfate, and keratan sulfate by liquid chromatography-electrospray ionization-tandem mass spectrometry. Anal. Biochem. 467, 62–74 (2014). https://doi.org/10.1016/j.ab.2014.08.005
Whiteman, P.: The quantitative measurement of Alcian blue-glycosaminoglycan complexes. Biochem. J. 131, 343–350 (1973)
Terry, D.E., Chopra, R.K., Ovenden, J., Anastassiades, T.P.: Differential use of Alcian blue and toluidine blue dyes for the quantification and isolation of anionic glycoconjugates from cell cultures: application to proteoglycans and a high-molecular-weight glycoprotein synthesized by articular chondrocytes. Anal. Biochem. 285, 211–219 (2000). https://doi.org/10.1006/abio.2000.4761
Farndale, R.W., Sayers, C.A., Barrett, A.J.: A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect. Tissue Res. 9, 247–248 (1982)
Yokoyama, M., Tanaka, H., Yoshihara, S., Endo, M.: A method for the identification of sulfated glycopeptide by two-dimensional electrophoresis on cellulose acetate membrane. J. Biochem. Biophys. Methods. 12, 239–246 (1986)
Bitter, T., Muir, H.M.: A modified uronic acid carbazole reaction. Anal. Biochem. 4, 330–334 (1962)
Whitley, C.B., Ridnour, M.D., Draper, K.A., Dutton, C.M., Neglia, J.P.: Diagnostic test for mucopolysaccharidosis. I. Direct method for quantifying excessive urinary glycosaminoglycan excretion. Clin. Chem. 35, 374–379 (1989)
Chandrasekhar, S., Esterman, M.A., Hoffman, H.A.: Microdetermination of proteoglycans and glycosaminoglycans in the presence of guanidine hydrochloride. Anal. Biochem. 161, 103–108 (1987)
Panin, G., Naia, S., Dall’Amico, R., Chiandetti, L., Zachello, F., Catassi, C., Felici, L., Coppa, G.V.: Simple spectrophotometric quantification of urinary excretion of glycosaminoglycan sulfates. Clin. Chem. 32, 2073–2076 (1986)
Stone, J.E., Akhtar, N., Botchway, S., Pennock, C.A.: Interaction of 1,9-dimethylmethylene blue with glycosaminoglycans. Ann. Clin. Biochem. 31(Pt 2), 147–152 (1994). https://doi.org/10.1177/000456329403100206
Zheng, C.H., Levenston, M.E.: Fact versus artifact: avoiding erroneous estimates of sulfated glycosaminoglycan content using the dimethylmethylene blue colorimetric assay for tissue-engineered constructs. Eur. Cell. Mater. 29, 224–236; discussion 236 (2015)
Kiran, G., Nandini, C.D., Ramesh, H.P., Salimath, P.V.: Progression of early phase diabetic nephropathy in streptozotocin-induced diabetic rats: evaluation of various kidney-related parameters. Indian J. Exp. Biol. 50, 133–140 (2012)
Lee, P.H.A., Trowbridge, J.M., Taylor, K.R., Morhenn, V.B., Gallo, R.L.: Dermatan sulfate proteoglycan and glycosaminoglycan synthesis is induced in fibroblasts by transfer to a three-dimensional extracellular environment. J. Biol. Chem. 279, 48640–48646 (2004). https://doi.org/10.1074/jbc.M407241200
Su, G., Meyer, K., Nandini, C.D., Qiao, D., Salamat, S., Friedl, A.: Glypican-1 is frequently overexpressed in human gliomas and enhances FGF-2 signaling in glioma cells. Am. J. Pathol. 168, 2014–2026 (2006). https://doi.org/10.2353/ajpath.2006.050800
Barbosa, I., Garcia, S., Barbier-Chassefière, V., Caruelle, J.-P., Martelly, I., Papy-García, D.: Improved and simple micro assay for sulfated glycosaminoglycans quantification in biological extracts and its use in skin and muscle tissue studies. Glycobiology. 13, 647–653 (2003). https://doi.org/10.1093/glycob/cwg082
Kinoshita, A., Sugahara, K.: Microanalysis of glycosaminoglycan-derived oligosaccharides labeled with a fluorophore 2-aminobenzamide by high-performance liquid chromatography: application to disaccharide composition analysis and exosequencing of oligosaccharides. Anal. Biochem. 269, 367–378 (1999). https://doi.org/10.1006/abio.1999.4027
Bigge, J.C., Patel, T.P., Bruce, J.A., Goulding, P.N., Charles, S.M., Parekh, R.B.: Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid. Anal. Biochem. 230, 229–238 (1995). https://doi.org/10.1006/abio.1995.1468
Deakin, J.A., Lyon, M.: A simplified and sensitive fluorescent method for disaccharide analysis of both heparan sulfate and chondroitin/dermatan sulfates from biological samples. Glycobiology. 18, 483–491 (2008). https://doi.org/10.1093/glycob/cwn028
Mikami, T., Kitagawa, H.: Sulfated glycosaminoglycans: their distinct roles in stem cell biology. Glycoconj. J. (2016). https://doi.org/10.1007/s10719-016-9732-9
Bishop, J.R., Schuksz, M., Esko, J.D.: Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature. 446, 1030–1037 (2007). https://doi.org/10.1038/nature05817
Handel, T.M., Johnson, Z., Crown, S.E., Lau, E.K., Proudfoot, A.E.: Regulation of protein function by glycosaminoglycans--as exemplified by chemokines. Annu. Rev. Biochem. 74, 385–410 (2005). https://doi.org/10.1146/annurev.biochem.72.121801.161747
Linhardt, R.J., Toida, T.: Role of glycosaminoglycans in cellular communication. Acc. Chem. Res. 37, 431–438 (2004). https://doi.org/10.1021/ar030138x
Jackson, R.L., Busch, S.J., Cardin, A.D.: Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol. Rev. 71, 481–539 (1991)
Gatto, F., Volpi, N., Nilsson, H., Nookaew, I., Maruzzo, M., Roma, A., Johansson, M.E., Stierner, U., Lundstam, S., Basso, U., Nielsen, J.: Glycosaminoglycan profiling in patients’ plasma and urine predicts the occurrence of metastatic clear cell renal cell carcinoma. Cell Rep. 15, 1822–1836 (2016). https://doi.org/10.1016/j.celrep.2016.04.056
De Muro, P., Capobianco, G., Lepedda, A.J., Nieddu, G., Formato, M., Tram, N.H.Q., Idini, M., Dessole, F., Dessole, S.: Plasma PP13 and urinary GAGs/DGs as early markers of pre-eclampsia. Arch. Gynecol. Obstet. 294, 959–965 (2016). https://doi.org/10.1007/s00404-016-4111-0
De Muro, P., Lepedda, A.J., Nieddu, G., Idini, M., Tram Nguyen, H.Q., Lobina, O., Fresu, P., Formato, M.: Evaluation of early markers of nephropathy in patients with type 2 diabetes mellitus. Biochem. Res. Int. 2016, 7497614 (2016). https://doi.org/10.1155/2016/7497614
Popławska-Kita, A., Mierzejewska-Iwanowska, B., Szelachowska, M., Siewko, K., Nikołajuk, A., Kinalska, I., Górska, M.: Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression. Diabetes Metab. Res. Rev. 24, 310–317 (2008). https://doi.org/10.1002/dmrr.808
Bower, L., Warren, C., Manley, G.: Human serum and urine glycosaminoglycans in health and in patients with chronic renal failure. Ann. Clin. Biochem. 29(Pt 2), 190–195 (1992). https://doi.org/10.1177/000456329202900212
Lazzeri, M., Hurle, R., Casale, P., Buffi, N., Lughezzani, G., Fiorini, G., Peschechera, R., Pasini, L., Zandegiacomo, S., Benetti, A., Taverna, G., Guazzoni, G., Barbagli, G.: Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence. Ther. Adv. Urol. 8, 91–99 (2016). https://doi.org/10.1177/1756287215621234
Pomin, V.H.: A dilemma in the glycosaminoglycan-based therapy: synthetic or naturally unique molecules? Med. Res. Rev. 35, 1195–1219 (2015). https://doi.org/10.1002/med.21356
Volpi, N.: Therapeutic applications of glycosaminoglycans. Curr. Med. Chem. 13, 1799–1810 (2006)
Templeton, D.M.: The basis and applicability of the dimethylmethylene blue binding assay for sulfated glycosaminoglycans. Connect. Tissue Res. 17, 23–32 (1988)
Acknowledgements
The authors acknowledge the funding of this study by SERB, DST, New Delhi (EMR/2015/000028) and Director for the keen interest. Shrikanth thanks CSIR for the Senior Research Fellowship.
Author information
Authors and Affiliations
Contributions
CBS and SJ did experiments, analysed data and wrote manuscript. CDN conceived the work, analysed data and wrote manuscript.
Corresponding author
Ethics declarations
Conflict of interest
None.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Shrikanth, C.B., Sanjana, J. & Chilkunda, N.D. One-pot analysis of sulfated glycosaminoglycans. Glycoconj J 35, 129–137 (2018). https://doi.org/10.1007/s10719-017-9809-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-017-9809-0